(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Leukemia
This study will evaluate the safety and effectiveness of a higher dosage of imatinib (an FDA approved drug) in people with chronic myeloid leukemia (CML) in the chronic phase. Volunteers 18-75 who are within six months of diagnosis of CML with cytogenetic confirmation of Philadelphia chromosome may be included. Females of childbearing age must have a negative serum pregnancy test within seven days prior to study drug initiation.
The research sites are located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat92.html.
-----
Asthma or Gastroesophageal Reflux Disease (GERD)
This study will evaluate the effects of the study drug esomeprazole among asthmatics. Participants must be between 18 and 70 with a clinical diagnosis of asthma, with a maintenance asthma treatment, and with symptoms of acid reflux for at least three months.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat16.html or
http://www.centerwatch.com/patient/studies/cat70.html .
-----
Erectile Dysfunction
If you have high cholesterol and erectile dysfunction (ED) you may qualify to participate in this clinical study of an approved medication, Levitra, for investigational use. Volunteers 18-64 who are taking a cholesterol lowering medication, having difficulty getting and keeping an erection, and who have been in a stable heterosexual relationship for six months may qualify.
The research site is in Walnut Creek, Calif.
More information
Please see http://www.centerwatch.com/patient/studies/cat371.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
